{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T08:46:28Z","timestamp":1779266788539,"version":"3.51.4"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,20]]},"DOI":"10.7759\/cureus.45590","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T10:08:41Z","timestamp":1695204521000},"source":"Crossref","is-referenced-by-count":2,"title":["Comprehensive Unloading Strategy for Rapid Heart Recovery Under Support With Impella"],"prefix":"10.7759","author":[{"given":"Masayoshi","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Ishizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Minami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daigo","family":"Hiraya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association","volume":"136","author":"van Diepen S","year":"2017","unstructured":"van Diepen S, Katz JN, Albert NM, et al.. Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association. Circulation. 2017, 136:e232-68. 10.1161\/CIR.0000000000000525","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.03.036","article-title":"2015 SCAI\/ACC\/HFSA\/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care: endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia intervencion\u202f; affirmation of value by the Canadian Association of Interventional Cardiology-Association canadienne de cardiologie d\u2019intervention","volume":"65","author":"Rihal CS","year":"2015","unstructured":"Rihal CS, Naidu SS, Givertz MM, et al.. 2015 SCAI\/ACC\/HFSA\/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care: endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia intervencion\u202f; affirmation of value by the Canadian Association of Interventional Cardiology-Association canadienne de cardiologie d\u2019intervention. J Am Coll Cardiol. 2015, 65:e7-e26. 10.1016\/j.jacc.2015.03.036","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh TA","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al.. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021, 42:3599-726. 10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa1012","article-title":"Heart failure drug treatment: the fantastic four","volume":"42","author":"Bauersachs J","year":"2021","unstructured":"Bauersachs J. Heart failure drug treatment: the fantastic four. Eur Heart J. 2021, 42:681-3. 10.1093\/eurheartj\/ehaa1012","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin-neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez EJ","year":"2019","unstructured":"Velazquez EJ, Morrow DA, DeVore AD, et al.. Angiotensin-neprilysin inhibition in acute decompensated heart failure. N Engl J Med. 2019, 380:539-48. 10.1056\/NEJMoa1812851","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01659-1","article-title":"The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial","volume":"28","author":"Voors AA","year":"2022","unstructured":"Voors AA, Angermann CE, Teerlink JR, et al.. The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial. Nat Med. 2022, 28:568-74. 10.1038\/s41591-021-01659-1","journal-title":"Nat Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.05.065","article-title":"A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction","volume":"52","author":"Seyfarth M","year":"2008","unstructured":"Seyfarth M, Sibbing D, Bauer I, et al.. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008, 52:1584-8. 10.1016\/j.jacc.2008.05.065","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg K","year":"2010","unstructured":"Swedberg K, Komajda M, B\u00f6hm M, et al.. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010, 376:875-85. 10.1016\/S0140-6736(10)61198-1","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12499","article-title":"Initiation of ivabradine in cardiogenic shock","volume":"6","author":"Chiu MH","year":"2019","unstructured":"Chiu MH, Howlett JG, Sharma NC. Initiation of ivabradine in cardiogenic shock. ESC Heart Fail. 2019, 6:1088-91. 10.1002\/ehf2.12499","journal-title":"ESC Heart Fail"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/ehjacc\/zuac133","article-title":"Heart rate control and haemodynamic improvement with ivabradine in cardiogenic shock patient on mechanical circulatory support","volume":"11","author":"Colombo CN","year":"2022","unstructured":"Colombo CN, Dammassa V, Klersy C, Camporotondo R, Pellegrini C, Mojoli F, Tavazzi G. Heart rate control and haemodynamic improvement with ivabradine in cardiogenic shock patient on mechanical circulatory support. Eur Heart J Acute Cardiovasc Care. 2022, 11:916-21. 10.1093\/ehjacc\/zuac133","journal-title":"Eur Heart J Acute Cardiovasc Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/186882-comprehensive-unloading-strategy-for-rapid-heart-recovery-under-support-with-impella","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:08:12Z","timestamp":1707509292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/186882-comprehensive-unloading-strategy-for-rapid-heart-recovery-under-support-with-impella"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,20]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.45590","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,20]]}}}